Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Sagunto

8 clinical trials in Sagunto, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Sagunto at a glance
8
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

8 trials in Sagunto

Open in trial search

IgA nephropathy

Recruiting

Study on Atrasentan for Patients with IgA Nephropathy at Risk of Kidney Function Loss

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Zigakibart
  • Sponsor:Novartis Pharma AG

Weaning failure

Recruiting

Study Comparing Non-Invasive Ventilation and High Flow Oxygen Therapy for Patients at Risk of Breathing Support Failure After Ventilator Removal

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Oxygen
  • Sponsor:Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:AstraZeneca AB

Breast cancer

Recruiting

Long-Term Study on Early Stage Breast Cancer Patients Using Capecitabine, Gemcitabine, and Paclitaxel

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Fundacion Grupo Espanol De Investigacion En Cancer De Mama

Study on the Effectiveness of Abemaciclib, Inavolisib, and Giredestrant in Patients with Early HR-positive/HER2-negative Breast Cancer

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Medica Scientia Innovation Research S.L.

Conjunctivitis allergic+3

Not recruiting

Study on the Effectiveness and Safety of Clustoid MM09 for Patients with Allergic Rhinitis or Rhinoconjunctivitis, with or without Mild to Moderate Asthma

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dermatophagoides Farinae Allergoid, Glutaraldehyde-Modified
  • Sponsor:Inmunotek S.L.

IgA nephropathy

Not recruiting

Study on the Effectiveness and Safety of Sparsentan and Dapagliflozin for Patients with Immunoglobulin A Nephropathy (IgAN)

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Travere Therapeutics Inc.

Lupus nephritis

Not recruiting

Study on the Effectiveness and Safety of Iptacopan with Drug Combination for Adults with Active Lupus Nephritis Class III-IV, +/- V

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Iptacopan
  • Sponsor:Novartis Pharma AG

Other cities in Spain

The busiest research cities in the country

All 214 cities in Spain

Clinical research in Sagunto

What the registry says about research in the country

01 Nephrology Research

Innovative studies focusing on IgA Nephropathy treatments, including evaluation of novel therapies like sparsentan and atrasentan for improving renal function and reducing proteinuria. Active research in lupus nephritis management explores new treatment combinations.

  • IgA Nephropathy Treatment
  • Lupus Nephritis Management
  • Renal Function Preservation
02 Breast Cancer Studies

Comprehensive research on early-stage breast cancer, particularly focusing on HR-positive/HER2-negative cases. Studies include monitoring minimal residual disease through ctDNA and evaluating extended endocrine therapy effectiveness.

  • Treatment Response Monitoring
  • Long-term Patient Outcomes
  • Hormone Receptor Positive Disease
03 Respiratory Medicine

Advanced research in respiratory care, including studies on mechanical ventilation weaning strategies and treatment of allergic conditions. Investigations include comparative analysis of non-invasive ventilation versus high-flow oxygen therapy.

  • Ventilation Management
  • Allergic Rhinitis Treatment
  • Respiratory Support Optimization
04 Inflammatory Conditions

Groundbreaking research in ulcerative colitis treatment using mirikizumab for long-term management. Studies aim to evaluate therapeutic effectiveness and patient outcomes in chronic inflammatory conditions.

  • Inflammatory Bowel Disease
  • Long-term Treatment Effects
  • Disease Management Strategies
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.